2BBBullish & Bearish
Health Care

Design Therapeutics, Inc. (DSGN) Stock Score & Signals

Design Therapeutics, Inc. (DSGN) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 18 out of 100.

2BB score and signals

Design Therapeutics, Inc.’s current 2BB score is 18 out of 100, built from the signal categories below.

SignalScoreReading
Activity10Very Low
Momentum50Stable
Financial strength29Weak
Quality80Very Strong
Risk45Moderate

Company facts

HeadquartersCarlsbad, California, United States
Founded2017
Employees55
52-week range$5.28 – $17.25

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-03-08—-0.4036—$0.00
2026-11-03—-0.3599—$0.00
2026-08-10—-0.3512—$0.00
2026-04-28-0.29-0.3349$0.00$0.00